Folic Acid, Parental Mutation Rates and the Risk for Neural Tube Defects

叶酸、亲本突变率和神经管缺陷的风险

基本信息

  • 批准号:
    8963563
  • 负责人:
  • 金额:
    $ 47.47万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2015
  • 资助国家:
    美国
  • 起止时间:
    2015-08-10 至 2020-06-30
  • 项目状态:
    已结题

项目摘要

 DESCRIPTION (provided by applicant): Birth defects are among the leading pediatric healthcare issues, yet there are few prevention strategies and the prevalence of birth defects in the US has remained relatively stable for decades, despite folic acid fortification of the food supply. Neural tube defects (NTDs) are among the most common and serious of all birth defects affecting 0.5-1 per 1,000 US newborns, yet their complex etiology remains poorly understood (Wallingford et al., 2013). It is well established that pre-pregnancy supplementation with folic acid can reduce the risk of NTDs, but the underlying mechanism of this beneficial effect is unclear. Approximately 30% of NTDs cannot be prevented by maternal periconceptional folate supplementation. Our preliminary data showed that rare mutations in planar cell polarity (PCP) pathway could increase the risk of NTDs, while mutagens such as polycyclic aromatic hydrocarbons were enriched in the placentas of NTDs fetuses/infants. We hypothesized that NTDs are caused by combinations of rare multiple mutations. Higher mutation rates results in a higher NTDs prevalence. It is possible that folic acid can prevent NTDs by reducing the mutation rate. Furthermore, we hypothesize that paternal supplementation with folic acid can further reduce NTD rates. We have a unique opportunity to evaluate folate supplement effect on mutation rate by leveraging previously collected biological samples from NTD patients and controls from several distinct cohorts. Additionally, we propose to use mouse models to better understand the relationship between folate and mutation rates in vivo. The results of this study will provide an explanation of how folate prevents NTDs, and will reveal novel pathways for intervention on folate-resistant NTDs. Hence, the successful completion of the proposed studies is likely to have substantial impact on our understanding of conditions that affect ~6% of births worldwide and constitute one of the major healthcare concerns for the youngest members of society.
 描述(申请人提供):出生缺陷是主要的儿科医疗保健问题之一,但几乎没有预防策略,尽管食品供应中添加了叶酸,但美国出生缺陷的流行率几十年来一直保持相对稳定。神经管缺陷(NTD)是所有出生缺陷中最常见和最严重的之一,影响每1000名美国新生儿中有0.5-1名,但其复杂的病因仍然知之甚少(Wallingford等人,2013年)。孕前补充叶酸可以降低NTDS的风险,这是公认的,但这种有益效果的潜在机制尚不清楚。大约30%的NTDS不能通过母体妊娠周补充叶酸来预防。我们的初步数据显示,平面细胞极性(PCP)途径的罕见突变会增加NTDS的风险,而NTDS胎儿/婴儿的胎盘中富含多环芳烃等诱变剂。我们假设NTDS是由罕见的多个突变组合引起的。更高的突变率会导致更高的NTDS患病率。叶酸可能通过降低突变率来预防NTDS。此外,我们假设父亲补充叶酸可以进一步降低NTD的发生率。我们有一个独特的机会,通过利用先前从NTD患者和来自几个不同队列的对照收集的生物样本来评估补充叶酸对突变率的影响。此外,我们建议使用小鼠模型来更好地了解体内叶酸和突变率之间的关系。这项研究的结果将为叶酸如何预防NTDS提供解释,并将揭示干预叶酸抵抗NTDS的新途径。因此,拟议研究的成功完成可能会对我们对影响全球约6%出生人口的疾病的理解产生重大影响,并构成社会最年轻成员的主要医疗保健问题之一。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

RICHARD H. FINNELL其他文献

RICHARD H. FINNELL的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('RICHARD H. FINNELL', 18)}}的其他基金

Understanding Genetic Complexity in Spina Bifida
了解脊柱裂的遗传复杂性
  • 批准号:
    10750235
  • 财政年份:
    2023
  • 资助金额:
    $ 47.47万
  • 项目类别:
12th International Conference on Neural Tube Defects
第十二届国际神经管缺陷会议
  • 批准号:
    10469136
  • 财政年份:
    2022
  • 资助金额:
    $ 47.47万
  • 项目类别:
Role of Slc25a32 and Its Interaction with Lrp6 in the Etiology of Neural Tube Defects
Slc25a32 的作用及其与 Lrp6 的相互作用在神经管缺陷病因学中的作用
  • 批准号:
    10355528
  • 财政年份:
    2020
  • 资助金额:
    $ 47.47万
  • 项目类别:
MicroRNA regulation of neural tube closure
MicroRNA对神经管闭合的调节
  • 批准号:
    10570194
  • 财政年份:
    2020
  • 资助金额:
    $ 47.47万
  • 项目类别:
Role of Slc25a32 and Its Interaction with Lrp6 in the Etiology of Neural Tube Defects
Slc25a32 的作用及其与 Lrp6 的相互作用在神经管缺陷病因学中的作用
  • 批准号:
    10577749
  • 财政年份:
    2020
  • 资助金额:
    $ 47.47万
  • 项目类别:
MicroRNA regulation of neural tube closure
MicroRNA对神经管闭合的调节
  • 批准号:
    10352211
  • 财政年份:
    2020
  • 资助金额:
    $ 47.47万
  • 项目类别:
MicroRNA regulation of neural tube closure
MicroRNA对神经管闭合的调节
  • 批准号:
    9885445
  • 财政年份:
    2020
  • 资助金额:
    $ 47.47万
  • 项目类别:
Biomechanics of Neural Tube Development using Brillouin-OCT Multimodality
使用布里渊-OCT 多模态进行神经管发育的生物力学
  • 批准号:
    9770703
  • 财政年份:
    2018
  • 资助金额:
    $ 47.47万
  • 项目类别:
Biomechanics of Neural Tube Development using Brillouin-OCT Multimodality
使用布里渊-OCT 多模态进行神经管发育的生物力学
  • 批准号:
    10194569
  • 财政年份:
    2018
  • 资助金额:
    $ 47.47万
  • 项目类别:
Biomechanics of Neural Tube Development using Brillouin-OCT Multimodality
使用布里渊-OCT 多模态进行神经管发育的生物力学
  • 批准号:
    10551412
  • 财政年份:
    2018
  • 资助金额:
    $ 47.47万
  • 项目类别:

相似海外基金

6-thio-2'-deoxyguanosine in GBM: Evaluation of Pharmaco-dynamics, Effects of Prior Standard of Care and A Human Phase 0 Study
GBM 中的 6-硫代-2-脱氧鸟苷:药效学评估、先前护理标准的影响和人类 0 期研究
  • 批准号:
    10305569
  • 财政年份:
    2021
  • 资助金额:
    $ 47.47万
  • 项目类别:
6-thio-2'-deoxyguanosine in GBM: Evaluation of Pharmaco-dynamics, Effects of Prior Standard of Care and A Human Phase 0 Study
GBM 中的 6-硫代-2-脱氧鸟苷:药效学评估、先前护理标准的影响和人类 0 期研究
  • 批准号:
    10488244
  • 财政年份:
    2021
  • 资助金额:
    $ 47.47万
  • 项目类别:
6-thio-2'-deoxyguanosine: A Novel Immunogenic Telomerase-Mediated Therapy in Glioblastoma - A Duke and UTSW Collaboration
6-硫代-2-脱氧鸟苷:一种新型免疫原性端粒酶介导的胶质母细胞瘤疗法 - 杜克大学和 UTSW 合作
  • 批准号:
    10305565
  • 财政年份:
    2021
  • 资助金额:
    $ 47.47万
  • 项目类别:
6-thio-2'-deoxyguanosine in GBM: Pre-clinical Evaluation of Mechanism of action, Efficacy and Biomarker identification
GBM 中的 6-硫代-2-脱氧鸟苷:作用机制、功效和生物标志物鉴定的临床前评估
  • 批准号:
    10488242
  • 财政年份:
    2021
  • 资助金额:
    $ 47.47万
  • 项目类别:
6-thio-2'-deoxyguanosine: A Novel Immunogenic Telomerase-Mediated Therapy in Glioblastoma - A Duke and UTSW Collaboration
6-硫代-2-脱氧鸟苷:一种新型免疫原性端粒酶介导的胶质母细胞瘤疗法 - 杜克大学和 UTSW 合作
  • 批准号:
    10488237
  • 财政年份:
    2021
  • 资助金额:
    $ 47.47万
  • 项目类别:
6-thio-2'-deoxyguanosine in GBM: Pre-clinical Evaluation of Mechanism of action, Efficacy and Biomarker identification
GBM 中的 6-硫代-2-脱氧鸟苷:作用机制、功效和生物标志物鉴定的临床前评估
  • 批准号:
    10305568
  • 财政年份:
    2021
  • 资助金额:
    $ 47.47万
  • 项目类别:
RUI: Chemical Investigations into the Bioactivity of the DNA Lesion 8-Oxo-2'-deoxyguanosine
RUI:DNA 损伤 8-Oxo-2-脱氧鸟苷生物活性的化学研究
  • 批准号:
    1903855
  • 财政年份:
    2019
  • 资助金额:
    $ 47.47万
  • 项目类别:
    Standard Grant
Toxicity and Biosensing Properties of C8-Aryl-Deoxyguanosine Adducts
C8-芳基-脱氧鸟苷加合物的毒性和生物传感特性
  • 批准号:
    311600-2013
  • 财政年份:
    2017
  • 资助金额:
    $ 47.47万
  • 项目类别:
    Discovery Grants Program - Individual
Toxicity and Biosensing Properties of C8-Aryl-Deoxyguanosine Adducts
C8-芳基-脱氧鸟苷加合物的毒性和生物传感特性
  • 批准号:
    311600-2013
  • 财政年份:
    2015
  • 资助金额:
    $ 47.47万
  • 项目类别:
    Discovery Grants Program - Individual
Toxicity and Biosensing Properties of C8-Aryl-Deoxyguanosine Adducts
C8-芳基-脱氧鸟苷加合物的毒性和生物传感特性
  • 批准号:
    311600-2013
  • 财政年份:
    2014
  • 资助金额:
    $ 47.47万
  • 项目类别:
    Discovery Grants Program - Individual
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了